Lnc-EST885 promotes hepatocellular carcinoma metastasis through PI3K / AKT pathway by interaction with TRAF4
lnc-EST885 plays a crucial role in the development of liver cancer, serving as a potential biomarker for predicting HCC prognosis and providing a new target for HCC treatment.
Authors
- Qicong Chen (ORCID: https://orcid.org/0000-0002-3903-5361)
- Shenhong Qu (ORCID: https://orcid.org/0000-0002-4141-327X)
- Shaoliang Zhu (ORCID: https://orcid.org/0000-0003-2573-023X)
- Lequn Li
- Juanmei Mo
- Gang Wang (ORCID: https://orcid.org/0000-0002-2288-3807)
- Zhi Li (ORCID: https://orcid.org/0000-0002-6437-0348)
- Honglin Luo
- Xiaofeng Dong
- Xiaoting Zou (ORCID: https://orcid.org/0000-0002-8999-4552)
- Weiwei Miao (ORCID: https://orcid.org/0000-0002-8726-2884)
- Huibing Chen (ORCID: https://orcid.org/0000-0002-1371-2192)
- Yuxuan Zhang (ORCID: https://orcid.org/0009-0001-8254-5025)
- Mengjie Zou (ORCID: https://orcid.org/0009-0006-4796-4968)
- Wenqian Nong
Institutions
- Guangxi University (CN)
- Guangxi Medical University (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine (CN)
- Guangxi University of Chinese Medicine (CN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Tumor Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1016/j.tranon.2024.102254
- Citations
- 2
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.57